Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
+14,386
New +$14.7M 0.71% 52
2024
Q1
Sell
-16,539
Closed -$9.63M 70
2023
Q4
$9.63M Hold
16,539
0.66% 51
2023
Q3
$9.07M Hold
16,539
0.67% 50
2023
Q2
$7.71M Hold
16,539
0.55% 58
2023
Q1
$5.63M Hold
16,539
0.45% 67
2022
Q4
$6.09M Hold
16,539
0.5% 60
2022
Q3
$5.45M Hold
16,539
0.45% 62
2022
Q2
$5.32M Buy
+16,539
New +$4.96M 0.42% 64
2021
Q1
Sell
-28,816
Closed -$4.87M 76
2020
Q4
$4.87M Buy
28,816
+1,246
+5% +$186K 0.45% 55
2020
Q3
$4.08M Hold
27,570
0.47% 49
2020
Q2
$4.53M Buy
+27,570
New +$4.23M 0.66% 41

Other funds holding LLY

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's LLY Position: Q2 2026 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet opened a new position in Eli Lilly (LLY) in Q2 2026: 14,386 shares worth $17.3M. The stake represents 0.71% of the portfolio and ranks #52 among its holdings. This is a return to the name: Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet previously reported a position in LLY as recently as Q4 2023.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in LLY in Q2 2020 and has held it in 11 quarters since. 3,701 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet held 14,386 shares of Eli Lilly worth $17.3M as of Q2 2026.
  • Eli Lilly was a new Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet position in Q2 2026.
  • Eli Lilly made up 0.71% of Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's portfolio in Q2 2026, its #52 holding.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Eli Lilly in Q2 2020 and has held it in 11 quarters since.
  • 3,701 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q2 2026, filed 5 Aug 2026.